Help! Please Register
global forex institute
  Education &
  Tools

  Introduction
  Abbreviations
  Links
  CME
  Conference
  Highlights
  Bibliography
  Glossary
  Good Books
  Events
  Calendar


  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank


  Mycoses

  Introduction
  Human
  Veterinary
  Environmental
  Industrial
  Agricultural


  Drugs

  Introduction
  Medical
  Veterinary
  Environmental
  Industrial
  Agricultural


  Laboratory

  Introduction
  Susceptibility
  MIC Database
  Procedures
  Histopathology


  About Us

  Introduction
  Our Mission
  Editorial Board
  Editorial Staff
  Supporters
  Contributors
  Legal Stuff
  Privacy Policy



This page updated:


DoctorFungus - All Rights Reserved © 2007 Copyright
& Privacy Policy


Site built and designed for doctorfungus by Webillustrated



You are here: Education & Tools >
Astellas Pharma Inc.

conference highlightsConference Highlights

Focus on Fungal Infections 13


Clinical Mycology
  1. IDENTIFICATION OF YEASTS OF CANDIDA SPECIES FROM PATIENTS WITH VULVOVAGINITIS IN THE AREA OF CARACAS, VENEZUELA
    de la Parte MA1, Brito A2, Mendoza M3, Alvarado P3, Mariño C2
    1Nursing School, Faculty of Medicine, Central University of Venezuela (UCV), Caracas, Venezuela
    2JM Vargas Medical School, Faculty of Medicine, UCV, Caracas, Venezuela
    3Mycology Laboratory, Institute of Biomedicine, Caracas, Venezuela.


  2. CANDIDEMIA IN HOSPITALIZED ADULTS: EPIDEMIOLOGY AND OUTCOMES IN THE UNITED STATES, 2000
    Zaoutis TE1, Chu JH1, Argon J2, Walsh TJ3 and Feudtner C2
    1Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, USA
    2Pediatric Generalist Research Group, Division of General Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, USA
    3Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, USA



  3. MULTICENTER RETROSPECTIVE DEVELOPMENT AND VALIDATION OF A CLINICAL PREDICTION RULE FOR INVASIVE CANDIDIASIS(IC) IN THE INTENSIVE CARE SETTING.
    Ostrosky-Zeichner L1, Sable C2, Sobel J1, Alexander B1, Donowitz G1, Kan V1, Kauffman CA1, Kett D1, Larsen R1, Morrison V1, Nucci M1, Pappas PG1, Bradley ME1, Major S3, Wallace D3, Rex JH1.
    1NIAID/BAMSG Candidiasis subgroup, Birmingham, USA
    2Merck & Co., Inc., Whitehouse Station USA
    3Rho/BAMBU, Chapel Hill, USA


  4. EARLY ONSET CANDIDA INFECTION IN THE NEONATE: RISKS AND TRENDS
    Rosenberg M1, Garb J2, Fisher D1
    1Baystate Medical Center Children's Hospital
    2Baystate Medical Center Department of Surgery, Tufts University School of Medicine, Springfield, USA



  5. OUTBREAK OF ASPERGILLUS USTUS INFECTIONS AMONG TRANSPLANT RECIPIENTS, SEATTLE, 1999-2003.
    Panackal AA, Imhof A, Hanley EW, Whittington N, Marr KA
    Fred Hutchinson Cancer Research Center; University of Washington, Seattle, U.S.A.


  6. INFECTIONS DUE TO SCEDOSPORIUM SPECIES IN AN ACADEMIC HOSPITAL IN BONN, GERMANY
    Horré R1,2, Schumacher G1, Schaal KP1, Sterzik B2, Schnitzler N2, Breuer G2, De Hoog GS3, Becker WHJ1,3, Choi SM1,3, Tintelnot K4
    1 Institute for Medical Microbiology and Immunology, University of Bonn, Germany
    2 Federal Institute for Drugs and Medical Devices, Bonn, Germany
    3 Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands
    4 Robert-Koch Institute, Berlin, Germany


top of page    




View other categories
Antifungal Agents | Antifungal Combinations | Antifungal Susceptibility | Basic Mycology
Case Reports | Clinical Mycology | Animal Models | Diagnostics | View All





  Home | Image Bank | Lecture Bank | Knowledgebase | Site Map | Contact Us |
The Fungi | Mycoses | Drugs |
Laboratory | Education & Tools | About Us

  mycosesstudygroup.org's sponsors